Speaker illustration

undefined undefined undefined

Assessing heart failure risk with CAVI: a blood pressure-independent arterial stiffness marker

Event: ESC Congress 2025

Topic: Biomarkers

Session: Cardiovascular risk assessment and secondary prevention

Thumbnail

Sacubitril/valsartan ameliorates doxorubicin-induced cardiomyocyte toxicity through inhibiting oxidative stress in rats

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure

Session: Basic science e-posters

Thumbnail

ESC 365 is supported by